Evidence map›Paper›PMID 26514619›Full record

Trial reportJournal of applied physiology (Bethesda, Md. : 1985)2016

Impact of 5-aminolevulinic acid with iron supplementation on exercise efficiency and home-based walking training achievement in older women.

Shizue Masuki, Atsumi Morita, Yoshi-ichiro Kamijo, Shigeki Ikegawa, Yufuko Kataoka, Yu Ogawa, Eri Sumiyoshi, Kiwamu Takahashi, Tohru Tanaka, Motowo Nakajima and 1 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of applied physiology (Bethesda, Md. : 1985), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shizue MasukiDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan; Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan; and.
Atsumi MoritaDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;
Yoshi-ichiro KamijoDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan; Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan; and.
Shigeki IkegawaDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;
Yufuko KataokaDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;
Yu OgawaDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;
Eri SumiyoshiDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;
Kiwamu TakahashiDepartment of R&D, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Tohru TanakaDepartment of R&D, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Motowo NakajimaDepartment of R&D, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Hiroshi NoseDepartment of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan; Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan; and nosehir@shinshu-u.ac.jp.
Shinshu University · JPSBI Pharmaceuticals (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0 °C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% (P < 0.001) and 11% (P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma (P < 0.001), although all remained unchanged in the CNT trial (P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial (P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% (P = 0.028), 102% (P = 0.027), and 69% (P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women.

Indexed as

Dietary SupplementsAccelerometryAgedAminolevulinic AcidCarbon DioxideCitric AcidCross-Over StudiesDietDouble-Blind MethodExerciseFemaleFerrous CompoundsHumansLactic AcidMiddle AgedOxygen ConsumptionAminolevulinic AcidCarbon DioxideCitric Acidferrous citrateFerrous CompoundsLactic Acid5-aminolevulinic acidexercise efficiencyhome-based walking training achievementrespiratory response

Identifiers

PMID26514619
PMCPMC4698441
OpenAlexW2177406690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.